BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 27531787)

  • 1. [ADAMTS13 Level in Prothrombotic Status and Its Related Factor Analysis].
    Sun CF; Liu GQ; Zhao X; Han F; Xu M; Xing J; Liu J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):1125-31. PubMed ID: 27531787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes of ADAMTS13 Activity and TSP1 Level in Patients with Hematologic Malignancies].
    Sun CF; Zhao X; Han F; Jia Q; Wang L; Lu G; Ding HF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1294-1298. PubMed ID: 27784345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels and activities of von Willebrand factor and metalloproteinase with thrombospondin type-1 motif, number 13 in inflammatory bowel diseases.
    Cibor D; Owczarek D; Butenas S; Salapa K; Mach T; Undas A
    World J Gastroenterol; 2017 Jul; 23(26):4796-4805. PubMed ID: 28765701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and significance of vWF, GMP-140 and ADAMTS13 in patients with aneurysmal subarachnoid hemorrhage.
    Li WH; Hui CJ; Ju H
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4350-4356. PubMed ID: 29077161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Von Willebrand Factor, ADAMTS13 and D-Dimer Are Correlated with Different Levels of Nephropathy in Type 1 Diabetes Mellitus.
    Domingueti CP; Dusse LM; Fóscolo RB; Reis JS; Annichino-Bizzacchi JM; Orsi FL; Mazetto Bde M; Carvalho Md; Gomes KB; Fernandes AP
    PLoS One; 2015; 10(7):e0132784. PubMed ID: 26168189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombospondin-1 and ADAMTS13 competitively bind to VWF A2 and A3 domains in vitro.
    Wang A; Liu F; Dong N; Ma Z; Zhang J; Su J; Zhao Y; Ruan C
    Thromb Res; 2010 Oct; 126(4):e260-5. PubMed ID: 20705333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADAMTS13 Retards Progression of Diabetic Nephropathy by Inhibiting Intrarenal Thrombosis in Mice.
    Dhanesha N; Doddapattar P; Chorawala MR; Nayak MK; Kokame K; Staber JM; Lentz SR; Chauhan AK
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1332-1338. PubMed ID: 28495930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A study on the significance of plasma thrombospondin1 in thrombotic thrombocytopenic purpura and the relationship between thrombospondin1 and von Willebrand factor cleaving protease (ADAMTS13)].
    Liu F; Lu GY; Dong NZ; Bai X; Su J; Ruan CG
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3190-3. PubMed ID: 16405838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between Von Willebrand factor, disintegrin and metalloproteinase with thrombospondin type 1 motif member 13, d-Dimer and cystatin C levels with retinopathy in type 1 diabetes mellitus.
    Domingueti CP; Fuzatto JA; Fóscolo RB; Reis JS; Dusse LM; Carvalho MDG; Gomes KB; Fernandes AP
    Clin Chim Acta; 2016 Aug; 459():1-4. PubMed ID: 27208743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variations in the ratio between von Willebrand factor and its cleaving protease during systemic inflammation and association with severity and prognosis of organ failure.
    Claus RA; Bockmeyer CL; Budde U; Kentouche K; Sossdorf M; Hilberg T; Schneppenheim R; Reinhart K; Bauer M; Brunkhorst FM; Lösche W
    Thromb Haemost; 2009 Feb; 101(2):239-47. PubMed ID: 19190805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Von Willebrand factor and ADAMTS13 activity as clinical severity markers in patients with COVID-19.
    Marco A; Marco P
    J Thromb Thrombolysis; 2021 Aug; 52(2):497-503. PubMed ID: 33866481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imbalance of von Willebrand factor and its cleaving protease ADAMTS13 during systemic inflammation superimposed on advanced cirrhosis.
    Reuken PA; Kussmann A; Kiehntopf M; Budde U; Stallmach A; Claus RA; Bruns T
    Liver Int; 2015 Jan; 35(1):37-45. PubMed ID: 25113276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia.
    Molvarec A; Rigó J; Bõze T; Derzsy Z; Cervenak L; Makó V; Gombos T; Udvardy ML; Hársfalvi J; Prohászka Z
    Thromb Haemost; 2009 Feb; 101(2):305-11. PubMed ID: 19190814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced ADAMTS13 in children with severe meningococcal sepsis is associated with severity and outcome.
    Bongers TN; Emonts M; de Maat MP; de Groot R; Lisman T; Hazelzet JA; Leebeek FW
    Thromb Haemost; 2010 Jun; 103(6):1181-7. PubMed ID: 20390223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The p.R1819_C1948delinsS mutation makes von Willebrand factor ADAMTS13-resistant and reduces its collagen-binding capacity.
    Daidone V; Saga G; Barbon G; Pontara E; Cattini MG; Morpurgo M; Zanotti G; Casonato A
    Br J Haematol; 2015 Aug; 170(4):564-73. PubMed ID: 25904363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute myocardial infarction as a systemic prothrombotic condition evidenced by increased von Willebrand factor protein over ADAMTS13 activity in coronary and systemic circulation.
    Horii M; Uemura S; Uemura M; Matsumoto M; Ishizashi H; Imagawa K; Iwama H; Takeda Y; Kawata H; Nakajima T; Fujimura Y; Saito Y
    Heart Vessels; 2008 Sep; 23(5):301-7. PubMed ID: 18810578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of plasma von Willebrand factor and its cleaving protease ADAMTS13 in patients with atrial fibrillation.
    Freynhofer MK; Gruber SC; Bruno V; Höchtl T; Farhan S; Zaller V; Wojta J; Huber K
    Int J Cardiol; 2013 Sep; 168(1):317-25. PubMed ID: 23041092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ratio of von Willebrand factor propeptide to ADAMTS13 is associated with severity of sepsis.
    Fukushima H; Nishio K; Asai H; Watanabe T; Seki T; Matsui H; Sugimoto M; Matsumoto M; Fujimura Y; Okuchi K
    Shock; 2013 May; 39(5):409-14. PubMed ID: 23481506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of plasma von Willebrand factor level and von Willebrand factor-cleaving protease activity in patients with chronic renal diseases.
    Lu GY; Shen L; Wang ZY; Guo XF; Bai X; Su J; Ruan CG
    Chin Med J (Engl); 2008 Jan; 121(2):133-6. PubMed ID: 18272039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High levels of von Willebrand factor and low levels of its cleaving protease, ADAMTS13, are associated with stroke in young HIV-infected patients.
    Allie S; Stanley A; Bryer A; Meiring M; Combrinck MI
    Int J Stroke; 2015 Dec; 10(8):1294-6. PubMed ID: 26121272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.